The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; none of the 68 sources its claims cite is checked for support yet.
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Open accessAbstract
Fuel Economy for Growing Cells: Sophisticated 21st-century analyses of the signaling pathways that control cell growth have led researchers back to the seminal work of Otto Warburg, who discovered in the 1920s that tumor cells generate their energy in an unusual way—by switching from mitochondrial respiration to glycolysis. The advantage conferred by this metabolic switch is puzzling because mitochondrial respiration is a more efficient way to produce ATP. Vander Heiden et al. (p. 1029 ) review arguments that rapidly growing cells have critical metabolic requirements that extend beyond ATP and that a better understanding of these requirements may shed new light on the “Warburg effect” and ultimately lead to new therapies for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 68 cited sources checked · 0 supported · 0 flagged
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“This 35-fold asymmetry is only partially compensated by the consumption of 3 glucose molecules in acetyl-CoA production to satisfy the carbon requirement of the acyl chain itself.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Some glucose must be diverted to macromolecular precursors such as acetyl-CoA for fatty acids, glycolytic intermediates for nonessential amino acids, and ribose for nucleotides.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Inhibiting LDH activity impairs cell proliferation (6)”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [6] Fantin VR St-Pierre J Leder P Cancer Cell 9 425 2006 16766262
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Most of the carbon for fatty acid synthesis is derived from glucose.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Normal proliferating cells can also undergo cell cycle arrest and reactivate catabolic metabolism when their ability to produce ATP from glucose is compromised (12, 13)”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Why Do Proliferating Cells Switch to a Less Efficient Metabolism?
What the sources say
- Not checked yetcites [12] Shaw RJ Proc Natl Acad Sci USA 101 3329 2004 14985505 PMC373461
- Not checked yetcites [13] Lum JJ Cell 120 237 2005 15680329
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“subsequent work showed that mitochondrial function is not impaired in most cancer cells (5–7)”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Proliferating Mammalian Cells Exhibit Anabolic Metabolism
What the sources say
- Not checked yetcites [5] Weinhouse S Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 87 115 1976 136820
- Not checked yetcites [6] Fantin VR St-Pierre J Leder P Cancer Cell 9 425 2006 16766262
- Not checked yetcites [7] Moreno-Sanchez R Rodriguez-Enriquez S Marin-Hernandez A Saavedra E FEBS J 274 1393 2007 17302740
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“This may explain at least part of the selective advantage provided by the Warburg effect”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [16] DeBerardinis RJ Proc Natl Acad Sci USA 104 19345 2007 18032601 PMC2148292
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“To produce two viable daughter cells at mitosis, a proliferating cell must replicate all of its cellular contents. This imposes a large requirement for nucleotides, amino acids, and lipids.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“even minor perturbations in the ATP/ADP ratio can impair growth”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Why Do Proliferating Cells Switch to a Less Efficient Metabolism?
What the sources say
- Not checked yetcites [10] Izyumov DS Biochim Biophys Acta 1658 141 2004 15282185
- Not checked yetcites [11] Vander Heiden MG Chandel NS Schumacker PT Thompson CB Mol Cell 3 159 1999 10078199
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose and glutamine supply most of the carbon, nitrogen, free energy, and reducing equivalents necessary to support cell growth and division”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: For most mammalian cells in culture, glucose and glutamine are the only two molecules catabolized in appreciable quantities.
- It may state two separate claims as one. 19
- Probably not a substantial claim. 6
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“to make a 16-carbon fatty acyl chain, a single glucose molecule can provide five times the ATP required, whereas 7 glucose molecules are needed to generate the NADPH required”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“synthesis of palmitate, a major constituent of cellular membranes, requires 7 molecules of ATP, 16 carbons from 8 molecules of acetyl-CoA (coenzyme A), and 28 electrons from 14 molecules of NADPH”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Synthesis of acetyl-CoA from citrate requires the enzyme ATP citrate lyase (ACL), and disruption of ACL impairs tumor growth (18).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [18] Hatzivassiliou G Cancer Cell 8 311 2005 16226706
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A second possible explanation for the switch to aerobic glycolysis, discussed in detail below, is that proliferating cells have important metabolic requirements that extend beyond ATP.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Why Do Proliferating Cells Switch to a Less Efficient Metabolism?
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Growth factor signaling also regulates the activity of the glycolytic enzyme pyruvate kinase and modulates flux of carbon through the later steps of glycolysis (9, 17).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [9] Christofk HR Nature 452 230 2008 18337823
- Not checked yetcites [17] Christofk HR Vander Heiden MG Wu N Asara JM Cantley LC Nature 452 181 2008 18337815
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“A glucose molecule can generate up to 36 ATPs, or 30 ATPs and 2 NADPHs [if diverted into the pentose phosphate shunt (8, 15)], or provide 6 carbons for macromolecular synthesis.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
- Not checked yetcites [15] Possibly up to four NADPH molecules per glucose can be produced if the products of the pentose phosphate shunt are metabolized via the TCA cycle and malic enzyme or cytosolic isocitrate dehydrogenase 1 (IDH1) to generate two additional NADPH molecules.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The metabolism of glucose to lactate generates only 2 ATPs per molecule of glucose, whereas oxidative phosphorylation generates up to 36 ATPs upon complete oxidation of one glucose molecule (8).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Why Do Proliferating Cells Switch to a Less Efficient Metabolism?
What the sources say
- Not checked yetcites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Glucose withdrawal induces cell death in a manner indistinguishable from that seen upon withdrawal of growth factor signaling, a phenomenon that may contribute to “oncogene addiction” (22).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
What the sources say
- Not checked yetcites [22] Vander Heiden MG Mol Cell Biol 21 5899 2001 11486029 PMC87309
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“PI3K signaling through AKT can regulate glucose transporter expression, enhance glucose capture by hexokinase, and stimulate phosphofructokinase activity (2)”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
What the sources say
- Not checked yetcites [2] Deberardinis RJ Lum JJ Hatzivassiliou G Thompson CB Cell Metab 7 11 2008 18177721
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Small molecules that disrupt PI3K signaling lead to decreased glucose uptake by tumors as measured by 18F-deoxyglucose positron emission tomography (FDG-PET), and the ability to inhibit tumor FDG uptake correlates with tumor regression (21).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
What the sources say
- Not checked yetcites [21] Engelman JA Nat Med 14 1351 2008 19029981 PMC2683415
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“p53 expression controls metabolic genes and alters glucose utilization”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Expression of TIGAR, a gene induced by p53, leads to inhibition of phosphofructokinase, redirection of glucose toward the pentose phosphate shunt, and NADPH production (34).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
What the sources say
- Not checked yetcites [34] Bensaad K Cell 126 107 2006 16839880
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Possibly the dumping of excess carbon as lactate is effective because it allows faster incorporation of carbon into biomass, which in turn facilitates rapid cell division.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“oncogenic Ras causes alterations in glucose metabolism (35) but causes senescence when expressed in cells without a cooperating oncogene (36)”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
What the sources say
- Not checked yetcites [35] Chiaradonna F Oncogene 25 5391 2006 16607279
- Not checked yetcites [36] Serrano M Lin AW McCurrach ME Beach D Lowe SW Cell 88 593 1997 9054499
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“The Cori cycle in the liver can recycle lactate generated from actively proliferating tissues to glucose, and analogous pathways exist to recycle the alanine generated from “inefficient” glutamine metabolism (8).”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Crunching the Numbers–What Are the Metabolic Needs of Proliferating Cells?
What the sources say
- Not checked yetcites [8] Lehninger AL Nelson DL Cox MM Principles of Biochemistry Worth New York 2 1993
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“IDH1 and IDH2 couple the interconversion of cytosolic isocitrate and α-ketoglutarate in an NADP+/NADPH-dependent reaction.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Mitochondrial oxidative phosphorylation is the major cellular source of ROS production.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Metabolic Regulation Is a Component of the Cell Growth Machinery
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“leukemic cells are highly glycolytic (40, 41), yet these cells reside within the bloodstream at higher oxygen tensions than cells in most normal tissues”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > What Triggers the Switch from Oxidative Phosphorylation to Aerobic Glycolysis?
What the sources say
- Not checked yetcites [40] Gottschalk S Anderson N Hainz C Eckhardt SG Serkova NJ Clin Cancer Res 10 6661 2004 15475456
- Not checked yetcites [41] Elstrom RL Cancer Res 64 3892 2004 15172999
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Perhaps one function of oncogenic pathways is to drive cell-autonomous nutrient uptake and program proliferative metabolism, whereas one function of tumor suppressor pathways is to prevent nutrient utilization for anabolic processes.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > What Triggers the Switch from Oxidative Phosphorylation to Aerobic Glycolysis?
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✗ Based: failsProbably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the available evidence suggests that it is a late-occurring event that may not be a major contributor in the switch to aerobic glycolysis by cancer cells”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > What Triggers the Switch from Oxidative Phosphorylation to Aerobic Glycolysis?
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“There is mounting evidence for cross-talk between signaling pathways and metabolic control in every multicellular organism studied.”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Future Prospects
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Metformin and the more potent related compound Phenformin activate AMPK in cells”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Cellular Metabolism and Human Cancer
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
In the paper
“the widely used diabetes drug metformin may offer a possible benefit in cancer prevention as well as improved outcomes when used with other cancer therapies (44)”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Cellular Metabolism and Human Cancer
What the sources say
- Not checked yetcites [44] Evans JM Donnelly LA Emslie-Smith AM Alessi DR Morris AD BMJ 330 1304 2005 15849206 PMC558205
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“a large fraction of human cancer is dependent on aberrant signaling through the PI3K/Akt pathway”
§ Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation > Cellular Metabolism and Human Cancer
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
The paper relies on this without support.
For most mammalian cells in culture, glucose and glutamine are the only two molecules catabolized in appreciable quantities.
“For most mammalian cells in culture, the only two molecules catabolized in appreciable quantities are glucose and glutamine.”
The paper relies on this without support.
Nutrients are not limiting for most proliferating cells.
“For most proliferating cells, nutrients are not limiting so there is no selective pressure to optimize metabolism for ATP yield.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“high levels of ROS generated by ongoing aerobic glycolysis followed by pyruvate oxidation in mitochondria (the Warburg effect), increase receptor and oncogene activity, and the stimulation of growth factor-dependent pathways or oxidizing enzymes induce genetic instability3,4.”
From ROS in cancer therapy: the bright side of the moon (2020) · cites this paper as [3]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As a result, the metabolic phenotype of immortalized cell lines may diverge from the native metabolic profile of their tissue of origin (Vander Heiden et al. 2009;Liberti and Locasale 2016).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Vander Heiden et al. 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the augmentation of aerobic glycolysis could aid in the mitigation of reactive oxygen species and additionally facilitate the production of a greater quantity of amino acids to support protein synthesis in osteoblasts [58].”
From Mesenchymal stromal cells in bone marrow niche of patients with multiple myeloma: a double-edged sword (2025) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The ATP that is necessary for fungal cell growth and function is synthesized mainly through oxidative phosphorylation (OXPHOS), with the key enzyme being F1Fo-ATP synthase4.”
From The δ subunit of F1Fo-ATP synthase is required for pathogenicity of Candida albicans (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PI3K signaling may be central to linking the common genetic perturbations of cancer, such as RTK mutations and PTEN loss, with altered metabolic processes, including the “lipogenic phenotype” common to many cancers, including GBM (13, 14, 17, 20).”
From An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway (2011) · cites this paper as [17]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“This metabolic reprogramming supports rapid and sustained proliferation by generating ATP, maintaining redox homeostasis, and diverting glycolytic intermediates into biosynthetic pathways required for macromolecular synthesis (Vander Heiden et al. 2009;Liberti and Locasale 2016).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Vander Heiden et al. 2009
The cited source says what the claim attributes to it.
In the citing paper
“In addition to these transcriptional and epigenetic concerns, CR may also influence the underlying metabolic state of primary cells, as sustained proliferation is generally associated with changes in growth-and survival-related signaling, biosynthetic demand, oxidative state, and energy use (Vander Heiden et al. 2009;Hoxhaj and Manning 2020).”
From Primary cell cultures versus immortalized cell lines: critical comparative insights into biological fidelity and translational applications (2026) · cites this paper as Vander Heiden et al. 2009
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, tumor suppressor pathways such as p53 and LKB1/ AMPK signaling also regulate cellular metabolism (Vander Heiden et al., 2009).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Vander Heiden et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Cancer cells preferentially metabolize glucose by aerobic glycolysis, a phenomenon known as the Warburg effect.”
From An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway (2011) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to gene expression changes, clustering analysis of proteins with temporal expression dynamics similar to gene expression changes reveals that electron transport chain proteins are downregulated in the first 3 days of reprogramming before a gradual metabolic switch to glycolysis, a characteristic that is typically seen in rapidly proliferating cells 84,97 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [97]
In the citing paper
“The Warburg effect, a preference for glycolysis and lactate secretion in the presence of oxygen, is an example of a metabolic property under cell-autonomous control by oncogenes in many proliferating cancer cells and tumors (1).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [1]
In the citing paper
“In 1924, Otto Warburg discovered that cancer cells metabolize glucose differently than cells of normal tissues: that even in conditions of sufficient oxygen availability, cancer cells convert glucose into lactate instead of using glucose for OXPHOS (208).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [208]
In the citing paper
“The carbon economy of a proliferating cell differs dramatically from that of a cell that is quiescent”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Vander Heiden et al., 2009
In the citing paper
“In healthy tissue, the fate of pyruvate is dependent on oxygen availability and mitochondrial respiratory capacity.14”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [14]
In the citing paper
“Otto Warburg observed that cancer cells rewire glucose metabolism for lactate synthesis even in normoxia, known as the Warburg Effect.14,21”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [14]
In the citing paper
“The recent resurgence of interest in the Warburg hypothesis and cancer energetics (66) emphasizes the dependence of many cancers on glycolysis for energy, creating a high requirement for glucose (or even “glucose addiction”), since ATP generation by glycolysis requires far more glucose than oxidative phosphorylation.”
From Diabetes and Cancer (2010) · cites this paper as [66]
In the citing paper
“This process, also known as the Warburg effect from earlier work in cancer biology, is a common trait of actively proliferating cells (5).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [5]
Citations
Cites
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
(1978) · Biochemical Education · doi:10.1016/0307-4412(78)90049-3 · Cited by 5,073
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Self-citationOverweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Warburg O., Posener K., Negelein E., Biochem. Z. 152, 319 (1924).
- Sonveaux P., et al.., J. Clin. Invest. 118, 3930 (2008).Medline
Cited by
Sorted by citations
Items 301–400 of 1,196
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2
Chen, J., Xie, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Oncogene · doi:10.1038/onc.2011.137 · Cited by 517
Glioblastoma: From Molecular Pathology to Targeted Treatment
Cloughesy, T. F., Cavenee, W. K., & Mischel, P. S. (2011) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130324 · Cited by 531
Redox-based reagents for chemoselective methionine bioconjugation
Lin, S., Yang, X., Jia, S., Weeks, A. M., Hornsby, M. J., Lee, P. S., Nichiporuk, R. V., Iavarone, A. T., Wells, J. A., Toste, F. D., et al. (2017) · Science · doi:10.1126/science.aal3316 · Cited by 520
Nishida, Y., Rardin, M. J., Carrico, C., He, W., Sahu, A. K., Gut, P., Najjar, R., Fitch, M., Hellerstein, M., Gibson, B. W., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.022 · Cited by 481
HIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Mathieu, J., Zhang, Z., Zhou, W., Wang, A. J., Heddleston, J. M., Pinna, C. M. A., Hubaud, A., Stadler, B., Choi, M. P., Bar, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3320 · Cited by 532
McNabney, S. M., & Henagan, T. M. (2017) · Nutrients · doi:10.3390/nu9121348 · Cited by 529
Therapeutically exploiting STAT3 activity in cancer — using tissue repair as a road map
Huynh, J., Chand, A. L., Gough, D. J., & Ernst, M. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0090-8 · Cited by 522
Resting state functional connectivity in preclinical Alzheimer’s disease
Sheline, Y. I., & Raichle, M. E. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.028 · Cited by 509
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Pollak, M. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0263 · Cited by 512
Imaging cytosolic NADH-NAD(+) redox state with a genetically encoded fluorescent biosensor
Hung, Y. P., Albeck, J. G., Tantama, M., & Yellen, G. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.012 · Cited by 509
Theranostic Fluorescent Probes
Sharma, A. K., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 512
PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis
Yang, L., Xie, M., Yang, M., Yu, Y., Zhu, S., Hou, W., Kang, R., Lotze, M. T., Billiar, T. R., Wang, H., et al. (2014) · Nature Communications · doi:10.1038/ncomms5436 · Cited by 509
Romero‐Garcia, S., Moreno‐Altamirano, M. M. B., Prado-García, H., & Sánchez‐García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 529
Zagato, E., Pozzi, C., Bertocchi, A., Schioppa, T., Saccheri, F., Guglietta, S., Fosso, B., Melocchi, L., Nizzoli, G., Troisi, J., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0649-5 · Cited by 492
Cancer associated fibroblasts: the dark side of the coin.
Cirri, P., & Chiarugi, P. (2011) · Europe PMC (PubMed Central) · Cited by 512
Mitochondrial Dysfunction in Cancer
Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 521
Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy
Rowe, I., Chiaravalli, M., Mannella, V., Ulisse, V., Quilici, G., Pema, M., Song, X. W., Xu, H., Mari, S., Qian, F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3092 · Cited by 503
Targeting antioxidants for cancer therapy
Glasauer, A., & Chandel, N. S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.017 · Cited by 516
Yang, E., Wang, X., Gong, Z., Yu, M., Wu, H., & Zhang, D. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00359-5 · Cited by 514
Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target
Infantino, V., Santarsiero, A., Convertini, P., Todisco, S., & Iacobazzi, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115703 · Cited by 541
The multifaceted functions of sirtuins in cancer
Chalkiadaki, A., & Guarente, L. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3985 · Cited by 513
PKM2, function and expression and regulation
Zhang, Z., Deng, X., Liu, Y., Liu, Y., Sun, L., & Chen, F. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0317-8 · Cited by 518
Metabolic regulation of homologous recombination repair by MRE11 lactylation
Chen, Y., Wu, J., Zhai, L., Zhang, T., Yin, H. M., Gao, H., Zhao, F., Wang, Z., Yang, X., Jin, M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.022 · Cited by 513
Oncogenic K‐Ras decouples glucose and glutamine metabolism to support cancer cell growth
Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Alberghina, L., Stephanopoulos, G., & Chiaradonna, F. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.56 · Cited by 492
Activation of fibroblasts in cancer stroma
Räsänen, K., & Vaheri, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.032 · Cited by 499
Redox regulation of immunometabolism
Muri, J., & Köpf, M. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00478-8 · Cited by 519
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 545
Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497
Panopoulos, A. D., Yanes, Ó., Ruiz, S., Kida, Y. S., Diep, D. H., Tautenhahn, R., Herrerias, A., Batchelder, E. M., Plongthongkum, N., Lutz, M. K., et al. (2011) · Cell Research · doi:10.1038/cr.2011.177 · Cited by 510
Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
Sivanand, S., & Heiden, M. G. V. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.011 · Cited by 498
Chloroquine in Cancer Therapy: A Double-Edged Sword of Autophagy
Kimura, T., Takabatake, Y., Takahashi, A., & Isaka, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2464 · Cited by 506
McDonald, O. G., Li, X., Saunders, T., Tryggvadottir, R., Mentch, S. J., Warmoes, M. O., Word, A. E., Carrer, A., Salz, T. H., Natsume, S., et al. (2017) · Nature Genetics · doi:10.1038/ng.3753 · Cited by 494
Phan, L. M., Yeung, S. J., & Lee, M. H. (2014) · Europe PMC (PubMed Central) · doi:10.7497/j.issn.2095-3941.2014.01.001 · Cited by 512
Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
Cheng, T., Sudderth, J., Yang, C., Mullen, A. R., Jin, E. S., Matés, J. M., & DeBerardinis, R. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016627108 · Cited by 475
Therapeutic targeting of the hypoxic tumour microenvironment
Singleton, D. C., Macann, A., & Wilson, W. R. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00539-4 · Cited by 507
Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target
Zhang, J., Xiang, H., Liu, J., Chen, Y., He, R.-R., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.45922 · Cited by 503
The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
Powell, J. D., & Delgoffe, G. M. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.002 · Cited by 503
3D cell culture systems modeling tumor growth determinants in cancer target discovery
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.03.001 · Cited by 478
Metformin in Cancer Treatment and Prevention
Morales, D. R., & Morris, A. D. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-062613-093128 · Cited by 494
Brown, T., & Ganapathy, V. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107451 · Cited by 518
For better or for worse: the role of Pim oncogenes in tumorigenesis
Nawijn, M. C., Alendar, A., & Berns, A. J. M. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2986 · Cited by 492
Liu, W., Le, A., Hancock, C., Lane, A. N., Dang, C. V., Fan, T. W.-M., & Phang, J. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203244109 · Cited by 483
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Dahia, P. L. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3648 · Cited by 545
Biodegradable Polymer Nanogels for Drug/Nucleic Acid Delivery
Li, Y., Maciel, D., Rodrigues, J., Shi, X., & Tomás, H. (2015) · Chemical Reviews · doi:10.1021/cr500131f · Cited by 480
Lipogenesis and lipolysis: The pathways exploited by the cancer cells to acquire fatty acids
Zaidi, N., Lupien, L. E., Kuemmerle, N. B., Kinlaw, W. B., Swinnen, J. V., & Smans, K. A. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.08.005 · Cited by 480
The Akt kinases: Isoform specificity in metabolism and cancer
Gonzalez, E., & McGraw, T. E. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9335 · Cited by 485
Predicting selective drug targets in cancer through metabolic networks
Folger, O., Jerby‐Arnon, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.35 · Cited by 480
Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A., Whitmore, A. C., Hillhouse, A., Curry, K. P., Renner, S. W., Greenwalt, A., Ryan, E. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0501 · Cited by 489
Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation
Lock, R., Roy, S., Kenific, C. M., Su, J. S., Salas, E., Ronen, S. M., & Debnath, J. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0500 · Cited by 467
Lin28: Primal Regulator of Growth and Metabolism in Stem Cells
Shyh-Chang, N., & Daley, G. Q. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.005 · Cited by 458
Cancer as a metabolic disease: implications for novel therapeutics
Seyfried, T. N., Flores, R. E., Poff, A. M., & D’Agostino, D. P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt480 · Cited by 497
Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis
Green, C. R., Wallace, M., Divakaruni, A. S., Phillips, S. A., Murphy, A. N., Ciaraldi, T. P., & Metallo, C. M. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1961 · Cited by 471
Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal
Zhang, J., Nuebel, E., Daley, G. Q., Koehler, C. M., & Teitell, M. A. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.10.005 · Cited by 477
Lipids in the tumor microenvironment: From cancer progression to treatment
Corn, K. C., Windham, M. A., & Rafat, M. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101055 · Cited by 486
Pike, L. S., Smift, A., Croteau, N. J., Ferrick, D. A., & Wu, M. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.022 · Cited by 482
Moschoi, R., Imbert, V., Nebout, M., Chiche, J., Mary, D. A. S. G., Prébet, T., Saland, E., Castellano, R., Pouyet, L., Collette, Y., et al. (2016) · Blood · doi:10.1182/blood-2015-07-655860 · Cited by 467
Irizarry-Caro, R. A., McDaniel, M. M., Overcast, G. R., Jain, V. G., Troutman, T. D., & Pasare, C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2009778117 · Cited by 472
Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Spinelli, J. B., Yoon, H., Ringel, A. E., Jeanfavre, S., Clish, C. B., & Haigis, M. C. (2017) · Science · doi:10.1126/science.aam9305 · Cited by 468
“However, in the tumor microenvironment, metabolic waste such as lactate and ammonia accumulate (4, 5).”
Background2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
Zhang, D., Li, J., Wang, F., Hu, J. X., Wang, S., & Sun, Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.003 · Cited by 477
Cancer-associated adipocytes: key players in breast cancer progression
Wu, Q., Li, B., Li, Z., Li, J., Sun, S., & Sun, S. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0778-6 · Cited by 462
From Ancient Pathways to Aging Cells—Connecting Metabolism and Cellular Senescence
Wiley, C. D., & Campisi, J. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.010 · Cited by 440
Pre-mRNA splicing in disease and therapeutics
Singh, R. K., & Cooper, T. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.006 · Cited by 472
IDH1andIDH2Mutations in Tumorigenesis: Mechanistic Insights and Clinical Perspectives
Yang, H., Ye, D., Guan, K., & Xiong, Y. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1773 · Cited by 477
The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Hoppe‐Seyler, K., Bossler, F., Braun, J. A., Herrmann, A. L., & Hoppe‐Seyler, F. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.07.007 · Cited by 475
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Pastoreková, S., & Gillies, R. J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09799-0 · Cited by 473
Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
Zhang, J., Fan, J., Venneti, S., Cross, J. R., Takagi, T., Bhinder, B., Djaballah, H., Kanai, M., Cheng, E. H., Judkins, A. R., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.018 · Cited by 439
Self-citationWnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Pate, K. T., Stringari, C., Sprowl‐Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., McQuade, M. M., Garner, C., Digman, M. A., Teitell, M. A., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201488598 · Cited by 459
Metabolic flux and the regulation of mammalian cell growth
Locasale, J. W., & Cantley, L. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.07.014 · Cited by 449
Self-citationImp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cellsPreprint
Janiszewska, M., Suvà, M. L., Riggi, N., Houtkooper, R. H., Auwerx, J. H., Clément‐Schatlo, V., Radovanovic, I., Rheinbay, E., Provero, P., & Stamenkovic, I. (2012) · Genes & Development · doi:10.1101/gad.188292.112 · Cited by 454
Phototherapy in cancer treatment: strategies and challenges
Cai, Y., Chai, T., Nguyen, W., Liu, J., Xiao, E., Ran, X., Ran, Y., Du, D., Chen, W., & Chen, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02140-y · Cited by 453
Expression of glucose transporters in cancers
Szablewski, L. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.12.004 · Cited by 453
Guo, D., Reinitz, F., Youssef, M., Hong, C., Nathanson, D., Akhavan, D., Kuga, D., Amzajerdi, A. N., Soto, H., Zhu, S., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0102 · Cited by 452
“PI3K signaling may be central to linking the common genetic perturbations of cancer, such as RTK mutations and PTEN loss, with altered metabolic processes, including the “lipogenic phenotype” common to many cancers, such as GBM (13, 14, 17, 20).”
Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells
Chen, H., & Chan, D. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.016 · Cited by 456
The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation
Tornatore, L., Thotakura, A. K., Bennett, J., Moretti, M., & Franzoso, G. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.08.001 · Cited by 461
Immunometabolism: Cellular Metabolism Turns Immune Regulator
Loftus, R. M., & Finlay, D. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.693903 · Cited by 460
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Reitman, Z. J., Jin, G., Karoly, E. D., Spasojevic, I., Yang, J., Kinzler, K. W., He, Y., Bigner, D. D., Vogelstein, B., & Yan, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019393108 · Cited by 449
The complexity of the Nrf2 pathway: beyond the antioxidant response
Huang, Y. S., Li, W., Su, Z., & Kong, A. T. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.001 · Cited by 460
Metabolic Regulation by p53 Family Members
Berkers, C. R., Maddocks, O. D. K., Cheung, E. C., Mor, I., & Vousden, K. H. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.019 · Cited by 458
Zhang, L., Wang, Z., Zhang, Y., Cao, F., Dong, K., Ren, J., & Qu, X. (2018) · ACS Nano · doi:10.1021/acsnano.8b05200 · Cited by 447
Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice
Gong, G., Song, M., Csordás, G., Kelly, D. P., Matkovich, S. J., & Dorn, G. W. (2015) · Science · doi:10.1126/science.aad2459 · Cited by 451
Energy Metabolism of the Osteoblast: Implications for Osteoporosis
Lee, W.-C., Guntur, A. R., Long, F., & Rosen, C. J. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00064 · Cited by 443
Lactate metabolism: historical context, prior misinterpretations, and current understanding
Ferguson, B. S., Rogatzki, M. J., Goodwin, M. L., Kane, D. A., Rightmire, Z. B., & Gladden, L. B. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-017-3795-6 · Cited by 485
Fan, J., Kamphorst, J. J., Mathew, R., Chung, M. K., White, E., Shlomi, T., & Rabinowitz, J. D. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.65 · Cited by 428
Gibb, A., Lazaropoulos, M. P., & Elrod, J. W. (2020) · Circulation Research · doi:10.1161/circresaha.120.316958 · Cited by 467
Metabolic pathways in T cell fate and function
Gerriets, V. A., & Rathmell, J. C. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.01.010 · Cited by 444
Chan, C., Li, C., Yang, W., Gao, Y., Lee, S.-W., Feng, Z., Huang, H.-Y., Tsai, K. K., Flores, L. G., Shao, Y., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.065 · Cited by 440
Zhao, Y., Hu, Q., Cheng, F., Su, N., Wang, A., Zou, Y., Hu, H., Chen, X., Hai‐Meng, Z. H. O. U., Huang, X., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.009 · Cited by 442
Heterogeneity of tumor-induced gene expression changes in the human metabolic network
Hu, J., Locasale, J. W., Bielas, J. H., O'Sullivan, J., Sheahan, K., Cantley, L. C., Heiden, M. G. V., & Vitkup, D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2530 · Cited by 407
Self-citationMitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Santidrián, A. F., Matsuno‐Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding‐Habermann, B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64264 · Cited by 445
Rod-Derived Cone Viability Factor Promotes Cone Survival by Stimulating Aerobic Glycolysis
Aït-Ali, N., Fridlich, R., Millet-Puel, G., Clérin, E., Delalande, F., Jaillard, C., Blond, F., Perrocheau, L., Reichman, S., Byrne, L. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.023 · Cited by 423
The restless brain: How intrinsic activity organizes brain function
Raichle, M. E. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0172 · Cited by 433
El‐Sawy, H. S., Al-Abd, A. M., Ahmed, T. A., El‐Say, K. M., & Torchilin, V. P. (2018) · ACS Nano · doi:10.1021/acsnano.8b06104 · Cited by 436
LeFloch, R., Chiche, J., Marchiq, I., Naiken, T., Ilc, K., Murray, C. M., Critchlow, S. E., Roux, D., Simon, M., & Pouysségur, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106123108 · Cited by 445
Lactate is always the end product of glycolysis
Rogatzki, M. J., Ferguson, B. S., Goodwin, M. L., & Gladden, L. B. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00022 · Cited by 428
The Power of Plasticity—Metabolic Regulation of Hepatic Stellate Cells
Trivedi, P., Wang, S., & Friedman, S. L. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.026 · Cited by 427
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
Hypoxia. 2. Hypoxia regulates cellular metabolism
Wheaton, W. W., & Chandel, N. S. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00485.2010 · Cited by 426
Role of Endothelial Cell Metabolism in Vessel Sprouting
Bock, K. D., Γεωργιάδου, Μ., & Carmeliet, P. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.001 · Cited by 437
Overcoming anoikis – pathways to anchorage-independent growth in cancer
Guadamillas, M. C., Cerezo, A., & del Pozo, M. Á. (2011) · Journal of Cell Science · doi:10.1242/jcs.072165 · Cited by 440
Classifying the evolutionary and ecological features of neoplasms
Maley, C. C., Aktipis, A., Graham, T. A., Sottoriva, A., Boddy, A. M., Janiszewska, M., Silva, A. S., Gerlinger, M., Yuan, Y., Pienta, K. J., et al. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.69 · Cited by 435
Metadata
- Authors
- Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B.
- Affiliations
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
- Harvard University (US)
- Abramson Cancer Center (US)
- Corresponding author
- Cantley, Lewis C.
- Thompson, Craig B.
- Venue
- Science
- Published
- 2009-05-22
- Volume
- 324
- Issue
- 5930
- Pages
- 1029-1033
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2849637
- OpenAlex
- W2097259163
- Semantic Scholar
- 5a3b09333eb2968904933e726dc29625e10eb188
- Cited by
- 16,197
- References
- 47
- Citations by year
- 2026: 969 · 2025: 1224 · 2024: 1225 · 2023: 1156 · 2022: 1351 · 2021: 1439 · 2020: 1276 · 2019: 1065 · 2018: 1028 · 2017: 1027 · 2016: 921 · 2015: 823 · 2014: 727 · 2013: 665 · 2012: 535
- FWCI
- 27.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA092660, R01CA105463, T32CA009172)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- Warburg effect, aerobic glycolysis, cancer metabolism, cell proliferation, mitochondrial oxidative phosphorylation, ATP production, signaling pathways, cancer-associated mutations, growth regulation
- MeSH terms
- Adenosine Triphosphate, Aerobiosis, Amino Acids, Animals, Glucose, Glycolysis, Humans, Lipids, Mutation, Neoplasms, Nucleotides, Oxidative Phosphorylation, Signal Transduction, Cell Proliferation, Metabolic Networks and Pathways
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
